Kerstin Stenson to Dose-Response Relationship, Drug
This is a "connection" page, showing publications Kerstin Stenson has written about Dose-Response Relationship, Drug.
Connection Strength
0.107
-
Efficacy and safety of treating T4 oral cavity tumors with primary chemoradiotherapy. Head Neck. 2009 Aug; 31(8):1013-21.
Score: 0.082
-
Phase II study of gefitinib adaptive dose escalation to skin toxicity in recurrent or metastatic squamous cell carcinoma of the head and neck. Oral Oncol. 2012 Sep; 48(9):887-92.
Score: 0.025